Singapore markets closed

Omega Therapeutics, Inc. (OMGA)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
2.0700-0.1700 (-7.59%)
At close: 04:00PM EDT
2.1100 +0.04 (+1.93%)
After hours: 07:59PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 114.72M
Enterprise value 182.30M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)23.23
Price/book (mrq)2.77
Enterprise value/revenue 36.92
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 1.90
52-week change 3-56.96%
S&P500 52-week change 322.55%
52-week high 36.3000
52-week low 31.3000
50-day moving average 32.2235
200-day moving average 32.7347

Share statistics

Avg vol (3-month) 3477.92k
Avg vol (10-day) 3881.82k
Shares outstanding 555.16M
Implied shares outstanding 655.16M
Float 821.32M
% held by insiders 11.62%
% held by institutions 194.98%
Shares short (14 Jun 2024) 45.24M
Short ratio (14 Jun 2024) 412.46
Short % of float (14 Jun 2024) 427.34%
Short % of shares outstanding (14 Jun 2024) 49.50%
Shares short (prior month 15 May 2024) 44.96M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 0.00%
Operating margin (ttm)-866.57%

Management effectiveness

Return on assets (ttm)-34.89%
Return on equity (ttm)-112.29%

Income statement

Revenue (ttm)4.94M
Revenue per share (ttm)0.09
Quarterly revenue growth (yoy)357.40%
Gross profit (ttm)N/A
EBITDA -93.25M
Net income avi to common (ttm)-92.28M
Diluted EPS (ttm)-1.6600
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)60.03M
Total cash per share (mrq)1.09
Total debt (mrq)127.61M
Total debt/equity (mrq)308.59%
Current ratio (mrq)2.87
Book value per share (mrq)0.75

Cash flow statement

Operating cash flow (ttm)-75.2M
Levered free cash flow (ttm)-47.34M